Related Experiment Videos
Calcium antagonists in hypertension: relation to abnormal sodium transport
Insights
Essential hypertension patients showed no link between blood pressure and leukocyte sodium levels. Nifedipine treatment lowered blood pressure but did not alter sodium efflux or intracellular sodium content.
Area of Science:
- Cardiovascular Medicine
- Cellular Physiology
Background:
- Essential hypertension is a complex condition with multifactorial origins.
- Alterations in cellular electrolyte transport, particularly sodium handling, have been implicated in hypertension pathogenesis.
- The role of the sodium pump and intracellular sodium content in blood pressure regulation remains an area of investigation.
Purpose of the Study:
- To investigate the relationship between leukocyte sodium efflux rate constants, intracellular electrolyte content, and blood pressure in patients with untreated essential hypertension.
- To determine if nifedipine treatment, a calcium channel blocker, affects these cellular parameters and influences blood pressure control.
- To evaluate the hypothesis that altered sodium transport contributes to hypertension and is corrected by calcium antagonist therapy.
Main Methods:
- Leucocyte sodium efflux rate constants and intracellular sodium and potassium content were measured in 13 patients with untreated essential hypertension.
- Measurements were repeated after one and three months of treatment with oral nifedipine, during which blood pressure was controlled.
- Statistical analysis was performed to assess correlations between blood pressure, electrolyte content, and efflux rates.
Main Results:
- No significant correlation was found between intracellular sodium or potassium content, or sodium efflux rate constant, and blood pressure in untreated patients.
- Following nifedipine treatment, blood pressure significantly decreased, but mean sodium efflux rate constant and intracellular sodium content remained unchanged.
- No correlation was observed between the fall in blood pressure and initial sodium efflux or intracellular sodium content.
Conclusions:
- The findings do not support a direct role for the sodium pump or intracellular sodium content in the generation of raised blood pressure in essential hypertension.
- Treatment of hypertension with calcium antagonists like nifedipine does not appear to correct a fundamental alteration in calcium-sodium exchange across the cell membrane related to sodium transport.
- Further research is needed to elucidate the complex mechanisms underlying essential hypertension and the precise role of cellular ion transport.
Abstract:
Leucocyte sodium efflux rate constants and intracellular electrolyte contents were estimated in 13 patients with untreated essential hypertension. There was no correlation between intracellular sodium or potassium content or efflux rate constant and blood pressure. The patients were then treated with oral nifedipine and blood pressure controlled. Sodium efflux rate constants and electrolyte contents were estimated one and three months after the start of treatment. There was a significant fall in blood pressure, but mean sodium efflux rate constant and intracellular sodium content were unchanged. There was no correlation between the fall in blood pressure, initial sodium efflux, or intracellular sodium content. These data do not support the hypothesis that the sodium pump and intracellular sodium content have a direct role in generating raised blood pressure, or that treatment of hypertension with calcium antagonists corrects a fundamental alteration of calcium-sodium exchange across the cell membrane.